Digital Therapeutic company, HealthBeacon, joined Irish and Brazilian Ministers for trade mission in São Paulo.
HealthBeacon joined Enterprise Ireland last week in São Paulo, Brazil with Irish Minister Pat Breen TD, Minister of State for Trade, Employment, Business, the EU Digital Single Market and Data Protection as part of a trade mission to Brazil. HealthBeacon and Minister Breen were hosted by AbbVie Pharmaceuticals at a working lunch with the key Brazilian government bodies in Education and Research as well as meeting with Brazil’s Minister of Science, Technology and Innovation, Mr. Gilberto Kassab. The Minister met with LATAM General Manager, Andrea Rangel, and North American Operations Director, Sean Glynn.
HealthBeacon has received full regulatory approval from Anatel and Anvisa to bring their smart sharps system into the Brazilian market. Brazil is a major market with millions of patients and is a key country in HealthBeacon’s global expansion strategy. The Brazil launch will represent the first market in South America with additional LATAM markets implementing shortly.
Enterprise Ireland will be hosting this trade mission focusing on Irish trade in Brazil and Latin America. Ireland is a proven innovation powerhouse, ranked a European leader for innovation in SMEs, employment impacts and sales impacts by the 2018 European Innovation Scoreboard:
- Ireland is rated by Bloomberg as one of the top 15 most innovative nations in the world
- Ireland ranks 11th globally for quality of its scientific research (Thomsson Reuters/Clarivate InCites, November 2017)
- Ireland ranks 6th in the IMD World Competitiveness ranking
- Ireland ranks 8th in Forbes Best Countries for Business ranking
Two-way trade between Ireland and Brazil continues to grow, with the combined trade in goods and services worth close to €1.8 billion in 2016. Irish Small and Medium Enterprises, such as those on this trade mission, have been shown a strong commitment to developing partnerships in the Brazilian market, increasing their sales here to over €42 million in 2017.
HealthBeacon is a Digital Therapeutics company that develops smart tools for managing medication. HealthBeacon has developed an injectable medication management system that tightly monitors patients digitally, keeping them adherent to their prescription and leveraging real time data to drive clinical intervention. This system has been clinically reviewed, validated by the pharmaceutical industry and has been integrated into patient care programs throughout North America and Europe, delivering valuable data to both the patient and their clinical team.